Publications in collaboration with researchers from University of Milan (16)

2023

  1. Mesoangioblasts at 20: From the embryonic aorta to the patient bed

    Frontiers in Genetics, Vol. 13

2014

  1. Targeting endothelial junctional adhesion molecule-A/ EPAC/ Rap-1 axis as a novel strategy to increase stem cell engraftment in dystrophic muscles

    EMBO Molecular Medicine, Vol. 6, Núm. 2, pp. 239-258

2012

  1. Erratum to: Isolation, Characterization and Differentiation Potential of Cardiac Progenitor Cells in Adult Pigs (Stem Cell Rev and Rep, 10.1007/s12015-011-9339-2)

    Stem Cell Reviews and Reports

  2. Isolation, Characterization and Differentiation Potential of Cardiac Progenitor Cells in Adult Pigs

    Stem Cell Reviews and Reports, Vol. 8, Núm. 3, pp. 706-719

  3. L-selectin and SDF-1 enhance the migration of mouse and human cardiac mesoangioblasts

    Cell Death and Differentiation, Vol. 19, Núm. 2, pp. 345-355

2011

  1. miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors

    Journal of Cell Biology, Vol. 193, Núm. 7, pp. 1197-1212

2010

  1. Mesoangioblasts from ventricular vessels can differentiate in vitro into cardiac myocytes with sinoatrial-like properties

    Journal of Molecular and Cellular Cardiology, Vol. 48, Núm. 2, pp. 415-423

2009

  1. Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency

    Cardiovascular Research, Vol. 83, Núm. 4, pp. 707-716

  2. Skeletal muscle differentiation of embryonic mesoangioblasts requires Pax3 activity

    Stem Cells, Vol. 27, Núm. 1, pp. 157-164

2008

  1. Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle

    Cell Death and Differentiation, Vol. 15, Núm. 9, pp. 1417-1428

2007

  1. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation

    Journal of Cell Biology, Vol. 179, Núm. 1, pp. 33-40

  2. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 1, pp. 264-269

  3. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells

    Nature Cell Biology, Vol. 9, Núm. 3, pp. 255-267

2006

  1. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability

    Journal of Cell Biology, Vol. 174, Núm. 2, pp. 231-243

  2. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy

    Journal of Cell Science, Vol. 119, Núm. 24, pp. 5114-5123

  3. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

    Nature, Vol. 444, Núm. 7119, pp. 574-579